Aptose Biosciences
APTO
$1.19
Share price
-1.65%
Change (1 day)
153.19%
Change (1 year)
Categories
Market capitalization of Aptose Biosciences (APTO)
Market cap: $19.54 Million
As of May 2024 Aptose Biosciences has a market cap of $19.54 Million. This makes Aptose Biosciences the world's 8004th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Aptose Biosciences from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $19.54 M | -3.24% |
| 2023 | $20.2 M | -65.84% |
| 2022 | $59.14 M | -50.99% |
| 2021 | $0.12 B | -69.03% |
| 2020 | $0.38 B | -9.01% |
| 2019 | $0.42 B | 487.85% |
| 2018 | $72.84 M | 21.74% |
| 2017 | $59.83 M | 231.26% |
| 2016 | $18.06 M | -42.2% |
| 2015 | $31.25 M | -54.86% |
| 2014 | $69.24 M | 176.99% |
| 2013 | $24.99 M | 89.87% |
| 2012 | $13.16 M | 225.61% |
| 2011 | $4.04 M | -73.69% |
| 2010 | $15.36 M | -16.92% |
| 2009 | $18.49 M | 137.54% |
| 2008 | $7.78 M | -79.87% |
| 2007 | $38.68 M | -16.42% |
| 2006 | $46.27 M | 6.79% |
| 2005 | $43.33 M | -58.04% |
| 2004 | $0.10 B | -20.83% |
| 2003 | $0.13 B | 173.7% |
| 2002 | $47.65 M | -58.18% |
| 2001 | $0.11 B |
End of Day market cap according to different sources
On May 16th, 2024 the market cap of Aptose Biosciences was reported to be:
$19.56 Million
$19.56 Million
$8.97 Million
$19.38 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | $8.72 B | 44,525.38% | 🇺🇸 USA |
 Corbus Pharmaceuticals
CRBP | $0.49 B | 2,410.16% | 🇺🇸 USA |
 Advaxis ADXS | $9.37 M | -52.07% | 🇺🇸 USA |